Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17β-estradiol

Circulation

Volumn 95, Issue 7, 1997, Pages 1954-1960

  Balica, Mihaela ^a   Boström, Kristina ^a   Shin, Victoria ^a   Tillisch, Kirsten ^a   Demer, Linda L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

atherosclerosis; calcium; hormones

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; ESTROGEN RECEPTOR; OSTEOCALCIN;

ANIMAL CELL; AORTA MEDIA; ARTERY CALCIFICATION; ARTICLE; CALCIUM CELL LEVEL; CATTLE; CELL COUNT; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME ASSAY; HORMONAL REGULATION; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TISSUE CULTURE;

EID: 0030948471     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.7.1954     Document Type: Article

References (69)

1. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15: 827-832.
2. Honye J, Mahon DJ, Jain A, White CJ, Ramee SR, Wallis JB, al-Zarka A, Tobis JM. Morphological effects on coronary balloon angioplasty in vivo assessed by intravascular ultrasound imaging. Circulation. 1992;85:1012-1025.
3. Baedenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol Rad Ther Nucl Med. 1964;92:865-871.
4. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty: an observational study using intravascular ultrasound. Circulation. 1992;86:64-70.
5. Detrano RC, Wong ND, Tang W, French WJ, Georgiou D, Young E, Brezden OS, Doherty TM, Narahara KA, Brundage BH. Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol. 1994;24:354-358.
6. Ohtsuka S, Kakihana M, Watanabe H, Sugishita Y. Chronically decreased aortic distensibility causes deterioration of coronary perfusion during increased left ventricular contraction. J Am Coll Cardiol. 1994;24:1406-1414.
7. Pearson AC, Guo R, Orsinelli DA, Binkley PF, Pasierski TJ. Transesophageal echocardiographic assessment of the effects of age, gender, and hypertension on thoracic aortic wall size, thickness, and stiffness. Am Heart J. 1994;128:344-352.
8. Hirsch D, Azoury R, Sarig S, Kruth HS. Colocalization of cholesterol and hydroxyapatite in human atherosclerotic lesions. Calcif Tissue Int. 1993;52:94-98.
9. Rumberger JA, Schwartz RS, Simons DB, Sheedy PF III, Edwards WD, Fitzpatrick LA. Relation of coronary calcium determined by electron beam computed tomography and lumen narrowing determined by autopsy. Am J Cardiol. 1994;73:1169-1173.
10. Bunting CH. The formation of true bone with cellular (red) marrow in a sclerotic aorta. J Exp Med. 1906;8:365-376.
11. Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest. 1993;91:1800-1809.
12. Schmid K, McSharry WO, Pameijer CH, Binette JP. Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. Atherosclerosis. 1980;37:199-210.
13. Anderson HC. Calcific diseases: a concept. Arch Pathol Lab Med. 1983;107:341-348.
14. Fleet JC, Hock JM. Identification of osteocalcin in mRNA in nonosteoid tissue of rats and human by reverse transcription-polymerase chain reaction. J Bone Miner Res. 1994;9:1565-1573.
15. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993;92:1686-1696.
16. Hirota S, Imakita M, Kohri K, Ito A, Morii E, Adachi S, Kim HM, Kitamura Y, Yutani C, Namura S. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques: a possible association with calcification. Am J Pathol. 1993;143:1003-1008.
17. Ikeda T, Shirasawa T, Esaki Y, Yoshiki S, Hirokawa K. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest. 1993;92:2814-2820.
18. Watson KE, Boström K, Ravindranath R, Lam T, Norton B, Demer LL. TGF-β1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest. 1994;93:2106-2113.
19. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H. β-Glycerophosphate accelerates calcification in cultured bovine smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995;15: 2003-2009.
20. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75:1102-1109.
21. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, Speizer FE, Hennekens CH. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
22. Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M, for the Atherosclerosis Risk in Communities Study Investigators. Association of hormone-replacement therapy with various cardiovascular risk factors on postmenopausal women. N Engl J Med. 1993;328:1069-1075.
23. Smith R. Prevention and treatment of osteoporosis: common sense and science coincide. J Bone Joint Surg (Br). 1994;76:345-347. Editorial.
24. Melton LJ III. How many women have osteoporosis now? J Bone Miner Res. 1995;10:175-177.
25. Alexander JJ, Hoenig M, Graham D, Imbembo AL. The effect of estrogen on low-density lipoprotein binding kinetics in aortic endothelial cells. Surgery. 1989;106:386-391.
26. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
27. Newnham HH. Oestrogens and atherosclerotic vascular disease: lipid factors. Baillieres Clin Endocrinol Metab. 1993;7:61-93.
28. Clarkson TB, Anthony MS, Klein K. Effects of estrogen treatment on arterial wall structure and function. Drugs. 1994;47(suppl 2):42-51.
29. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation. 1991;52:967-972.
30. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br J Pharmacol. 1993;109:612-617.
31. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA. Estrogen improves endothelium-dependent flow-mediated vasodilation in postmenopausal women. Ann Intern Med. 1994;121:936-941.
32. Salas E, López MG, Villarroya M, Sánchez-Garciá P, De Pascual R, Dixon WR, Garcia AG. Endothelium-independent relaxation by 17α-estradiol of pig coronary arteries. Eur J Pharmacol. 1994;258: 47-55.
33. Bar J, Tepper R, Fuchs J, Pardo Y, Goldberger S, Ovadia J. The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women. Obstet Gynecol. 1993;81:261-264.
34. Rifici VA, Khachadurian AK. The inhibition of low-density lipoprotein oxidation by 17-β estradiol. Metabolism. 1992;41: 1110-1114.
35. Negre-Salvayre A, Pieraggi M-T, Mabile L, Salvayre R. Protective effect of 17β-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis. 1993;99:207-217.
36. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg. 1994;19:722-726.
37. Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI. Hormone replacement therapy and the cardiovascular system: nonlipid effects. Drugs. 1994;47(suppl 2):35-41.
38. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TG, Riggs BL. Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 1988;241:84-86.
39. Ernst M, Parker MG, Rodan GA. Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol. 1991;5: 1597-1606.
40. Davis VL, Course JF, Gray TK, Korach KS. Correlation between low levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like cell lines. J Bone Miner Res. 1994;9:983-991.
41. Pensler JM, Radosevich JA, Higbee R, Langman CB. Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res. 1990;5: 797-802.
42. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992;257:88-91.
43. de Vernejoul M-C, Cohen-Solal M, Orcel P. Bone cytokines. Curr Opin Rheumatol. 1993;5:332-338.
44. Horowitz MC. Cytokines and estrogen in bone: anti-osteoporotic effects. Science. 1993;260:626-627.
45. Dent CE, Engelbrecht HE, Godfrey RC. Osteoporosis of lumbar vertebrae and calcification of abdominal aorta in women living in Durban. Br Med J. 1968;4:76-79.
46. Boukhris R, Becker KL. Calcification of the aorta and osteoporosis: a roentgenographic study. JAMA. 1972;219:1307-1311.
47. Moon J, Bandy B, Davison AJ. Hypothesis: etiology of atherosclerosis and osteoporosis - are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr. 1992;11:567-583.
48. Ernst M, Heath JK, Schmid C, Froesc RF, Rodan GA. Evidence for a direct effect of estrogen on bone cells in vitro. J Steroid Biochem. 1989;34:279-284.
49. Traish AM, Ettinger R, Kim N, Marshak-Rothstein A, Wotiz HH. Development and characterization of monoclonal antibodies to a specific domain of human estrogen receptor. Steroids. 1990;55: 196-208.
50. Webster WW Jr. A simple microspectrophotometric method for the determination of serum calcium. Am J Clin Pathol. 1962;37: 330-333.
51. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 1994;89:1943-1950.
52. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J-C. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995;136:1523-1529.
53. Young MF, Kerr JM, Ibaraki K, Heegaard AM, Robey PG. Structure, expression, and regulation of the major noncollagenous matrix proteins of bone. Clin Orthop. 1992;281:275-294.
54. Brandi ML, Crescioli C, Tanini A, Frediani U, Agnusdei D, Gennari C. Bone endothelial cells as estrogen targets. Calcif Tissue Int. 1993;53:312-317.
55. Campisi D, Cutolo M, Carruba G, Lo Casto M, Comito L, Granata OM, Valentino B, King RJB, Castagnetta L. Evidence for soluble and nuclear site I binding of estrogens in human aorta. Atherosclerosis. 1993;103:267-277.
56. Stein GS, Lian JB, Gerstenfeld LG, Shalhoub V, Aronow M, Owen T, Markose E. The onset and progression of osteoblast differentiation is functionally related to cellular proliferation. Connect Tissue Res. 1989;20:3-13.
57. Bellows CG, Aubin JE, Heersche JNM. Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. Bone Miner. 1991;14: 27-40.
58. Schwartz Z, Soskolne WA, Neubauer T, Goldstein M, Adi S, Ornoy A. Direct and sex-specific enhancement of bone formation and calcification by sex steroid in fetal mice long bone in vitro (biochemical and morphometric study). Endocrinology. 1991;129: 1167-1174.
59. Hashimoto J, Takaoka K, Yoshikawa H, Miyamoto S, Suzuki S, Ono K. Preservation of ectopically induced bone in the mouse by estradiol. Bone. 1991;12:249-255.
60. Gallagher A, Chambers TJ, Tobias JH. The estrogen antagonist ICI 182,780 reduces cancellous bone volume in female rats. Endocrinology. 1993;133:2787-2791.
61. Scheven BAA, Damen CA, Hamilton NJ, Verhaar HJJ, Duursma SA. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biophys Res Commun. 1992;186:54-60.
62. Majeska RJ, Ryaby JT, Einhorn TA. Direct modulation of osteoblastic activity with estrogen. J Bone Joint Surg. 1994;76-A:713-720.
63. Mathieu E, Merregaert J. Characterization of the stromal osteogenic cell line MN7: mRNA steady-state level of selected osteogenic markers depends on cell density and is influenced by 17β-estradiol. J Bone Miner Res. 1994;9:183-192.
64. Verhaar HJJ, Damen CA, Duursma SA, Scheven BAA. A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro. Bone. 1994;15:307-311.
65. Keeting PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL. Lack of direct effect of estrogen on proliferation and differentiation of normal human osteoblast-like cells. J Bone Miner Res. 1991;6:297-304.
66. el-Hajj Fuleihan G, Brown EM, Curtis K, Berger MJ, Berger BM, Gleason R, LeBoff MS. Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism. Arch Intern Med. 1992;152:1904-1909.
67. Ohta H, Ikeda T, Masuzawa T, Makita K, Suda Y, Nozawa S. Differences in axial bone mineral density, serum levels of sex steroids, and bone metabolism between postmenopausal and age-and body size-matched premenopausal subjects. Bone. 1993;14: 111-116.
68. Parthemore JG, Burton DW, Deftos LJ. Associations and dissociations between serum bone Gla protein and alkaline phosphatase in skeletal metabolism. J Orthop Res. 1993;11:671-676.
69. Rosenquist C, Bonde M, Fledelius C, Qvist P. A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem. 1994;40:1258-1264.